Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PETMED EXPRESS INCPETS · Entity 7326 | CAO and Interim CFO | June 26, 2026 | July 24, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PETMED EXPRESS INC
Report date June 26, 2026 · Filed July 24, 2026 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 102,500 |
Reported balance
After 2026-06-26 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2026-06-26 · Grant · Acquired 32,500 · Balance 102,500 F1: Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan that vests as to 50% of granted shares on June 26, 2027, and 50% on June 26, 2028, subject to continued employment through each such vesting date. |
| Performance Share UnitsSEC Table II · derivative / convertible security · Expires 2028-03-31 | Direct | 32,500 |
Reported balance
After 2026-06-26 transaction · row 2
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 2 · 2026-06-26 · Grant · Acquired 32,500 · Balance 32,500 F2: Performance Share Units ("PSUs") granted pursuant to the 2024 Omnibus Incentive Plan. Each PSU represents a contingent right to receive one share of the Company's Common Stock if predetermined levels of the Company's total shareholder return relative to the S&P 600 Specialty Retail Index are achieved over a two-year performance period beginning on April 1, 2026 ending on March 31, 2028. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan that vests as to 50% of granted shares on June 26, 2027, and 50% on June 26, 2028, subject to continued employment through each such vesting date.
F2: Performance Share Units ("PSUs") granted pursuant to the 2024 Omnibus Incentive Plan. Each PSU represents a contingent right to receive one share of the Company's Common Stock if predetermined levels of the Company's total shareholder return relative to the S&P 600 Specialty Retail Index are achieved over a two-year performance period beginning on April 1, 2026 ending on March 31, 2028.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 26, 2026 Filed Jun 26, 2026 20:07 UTC | PETMED EXPRESS INC PETS · Entity 7326 | GrantPerformance Share Units · Derivative | 32,500 | $0.00 | $0.00 |
DisclosureSEC source: 0002035815-26-000002 · wk-form4_1782504439.xml · derivative · entry 2 KRULIK DOUGLAS · CIK 0002035815 · CAO and Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,500 Underlying: Common Stock · 32,500 shares Expires 2028-12-31 F2 · derivative.exercise_price: Performance Share Units ("PSUs") granted pursuant to the Plan. Each PSU represents a contingent right to receive one share of the Company's Common Stock if predetermined levels of the Company's total shareholder return relative to the S&P 600 Specialty Retail Index are achieved over a three-year performance period ending on December 31, 2028. F2 · derivative.exercise_date: Performance Share Units ("PSUs") granted pursuant to the Plan. Each PSU represents a contingent right to receive one share of the Company's Common Stock if predetermined levels of the Company's total shareholder return relative to the S&P 600 Specialty Retail Index are achieved over a three-year performance period ending on December 31, 2028. Read SEC document |
| June 26, 2026 Filed Jun 26, 2026 20:07 UTC | PETMED EXPRESS INC PETS · Entity 7326 | GrantCommon Stock | 32,500 | $0.00 | $0.00 |
DisclosureSEC source: 0002035815-26-000002 · wk-form4_1782504439.xml · nonDerivative · entry 1 KRULIK DOUGLAS · CIK 0002035815 · CAO and Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,500 F1 · shares: Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan that vests as to 50% of granted shares on June 26, 2027, and 50% on June 26, 2028, subject to continued employment through each such vesting date. Read SEC document |
| June 26, 2026 Filed Jul 24, 2026 20:32 UTC Amendment | PETMED EXPRESS INC PETS · Entity 7326 | GrantPerformance Share Units · Derivative | 32,500 | $0.00 | $0.00 |
DisclosureSEC source: 0002035815-26-000004 · wk-form4a_1784925161.xml · derivative · entry 2 KRULIK DOUGLAS · CIK 0002035815 · CAO and Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,500 Underlying: Common Stock · 32,500 shares Expires 2028-03-31 F2 · derivative.exercise_price: Performance Share Units ("PSUs") granted pursuant to the 2024 Omnibus Incentive Plan. Each PSU represents a contingent right to receive one share of the Company's Common Stock if predetermined levels of the Company's total shareholder return relative to the S&P 600 Specialty Retail Index are achieved over a two-year performance period beginning on April 1, 2026 ending on March 31, 2028. F2 · derivative.exercise_date: Performance Share Units ("PSUs") granted pursuant to the 2024 Omnibus Incentive Plan. Each PSU represents a contingent right to receive one share of the Company's Common Stock if predetermined levels of the Company's total shareholder return relative to the S&P 600 Specialty Retail Index are achieved over a two-year performance period beginning on April 1, 2026 ending on March 31, 2028. Read SEC document |
| June 26, 2026 Filed Jul 24, 2026 20:32 UTC Amendment | PETMED EXPRESS INC PETS · Entity 7326 | GrantCommon Stock | 32,500 | $0.00 | $0.00 |
DisclosureSEC source: 0002035815-26-000004 · wk-form4a_1784925161.xml · nonDerivative · entry 1 KRULIK DOUGLAS · CIK 0002035815 · CAO and Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,500 F1 · shares: Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan that vests as to 50% of granted shares on June 26, 2027, and 50% on June 26, 2028, subject to continued employment through each such vesting date. Read SEC document |
| October 30, 2025 Filed Nov 3, 2025 21:08 UTC | PETMED EXPRESS INC PETS · Entity 7326 | GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0002035815-25-000011 · wk-form4_1762204117.xml · nonDerivative · entry 1 KRULIK DOUGLAS · CIK 0002035815 · CAO and Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,000 F1 · shares: Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan that vests as to 50% of granted shares on October 30, 2026, and 50% on October 30, 2027, subject to continued employment through each such vesting date. Read SEC document |
| September 09, 2025 Filed Sep 11, 2025 20:34 UTC | PETMED EXPRESS INC PETS · Entity 7326 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0002035815-25-000009 · wk-form4_1757622875.xml · nonDerivative · entry 1 KRULIK DOUGLAS · CIK 0002035815 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 F1 · acquired: Restricted stock award granted pursuant to the PetMed Express, Inc. (the "Company") 2024 Omnibus Incentive Plan (the "2024 Omnibus Plan"). The award will vest in its entirety on the 6-month anniversary of the grant date so long as Mr. Krulik remains on such date employed by the Company or otherwise in the service of the Company (as a director, consultant, or otherwise) and the award will vest in full in the event that the Company terminates the service by Mr. Krulik with the Company prior to the full vesting of the award unless such termination is for Cause (within the meaning 2024 Omnibus Plan). Read SEC document |
| September 27, 2024 Filed Sep 11, 2025 20:30 UTC | PETMED EXPRESS INC PETS · Entity 7326 | GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0002035815-25-000007 · wk-form4_1757622642.xml · nonDerivative · entry 1 KRULIK DOUGLAS · CIK 0002035815 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 F1 · shares: Restricted stock units ("RSUs") granted pursuant to the PetMed Express, Inc. (the "Company") 2024 Inducement Incentive Plan. One-third of the RSUs vest on each of the first, second and third anniversaries of September 27, 2024, subject to continued employment with the Company through the restricted periods (except as provided in the RSU agreement). Each RSU represents a right to receive one share of the Company's Common Stock upon vesting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.